The management of alcohol withdrawal in pregnancy - case report, literature review and preliminary recommendations

General Hospital Psychiatry

Volumn 37, Issue 3, 2015, Pages 273.e1-273.e3

  Bhat, Amritha ^a   Hadley, Allison ^b  

^a UNIVERSITY OF WASHINGTON   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Alcohol withdrawal; Benzodiazepine; Pregnancy; Teratogenicity

Indexed keywords

FLUOXETINE; LORAZEPAM; ALCOHOL; BENZODIAZEPINE DERIVATIVE;

ADULT; ALCOHOL CONSUMPTION; ALCOHOL WITHDRAWAL; ARTICLE; CASE REPORT; CESAREAN SECTION; FEMALE; GESTATION PERIOD; HOSPITAL ADMISSION; HOSPITAL DISCHARGE; HUMAN; MAJOR DEPRESSION; MICROCYTIC ANEMIA; PREGNANCY; UNIVERSITY HOSPITAL; CHEMICALLY INDUCED; PREGNANCY COMPLICATIONS; SUBSTANCE WITHDRAWAL SYNDROME;

ADULT; BENZODIAZEPINES; ETHANOL; FEMALE; HUMANS; PREGNANCY; PREGNANCY COMPLICATIONS; SUBSTANCE WITHDRAWAL SYNDROME;

EID: 84930178151     PISSN: 01638343     EISSN: 18737714     Source Type: Journal    
DOI: 10.1016/j.genhosppsych.2015.02.001     Document Type: Article

References (14)

1. Grant T.M., Huggins J.E., Sampson P.D., Ernst C.C., Barr H.M., Streissguth A.P. Alcohol use prior to and during pregnancy in western Washington, 1989-2004: implications for preventing fetal alcohol spectrum disorders. Am J Obstet Gynecol 2009, 200(3):278.e1-278.e8.
2. Sullivan J.T., Sykora K., Schneiderman J., Naranjo C.A., Sellers E.M. Assessment of alcohol withdrawal: the revised clinical institute withdrawal assessment for alcohol scale (CIWA-Ar). Br J Addict 1989, 84(11):1353-1357.
3. Heberlein A.L.L., Stichtenoth D., Hillemacher T. The treatment of alcohol and opioid dependence in pregnant women. Curr Opin Psychiatry 2012, 25:559-564.
4. Lingford - Hughes A.R., Welch S., Nutt D.J. Evidence-based guidelines for the pharmacological management of substance misuse, addiction and comorbidity: recommendations from the British Association for Psychopharmacology. J Psychopharmacol 2004, 18:293-333.
5. WHO [cited 2014. Nov 18]. http://www.who.int/substance:abuse/publications/pregnancy_guidelines/en/.
6. Detoxification and substance abuse treatment. (TIP) Series 2006, 45. Substance Abuse and Mental Health Services Administration, Center for Substance Abuse Treatment, Rockville (MD).
7. Laegreid L., Olegård R., Conradi N., Hagberg G., Wahlstrom J., Abrahamsson L. Association between congenital malformations and maternal consumption of benzodiazepines. A case-control study. Dev Med Child Neurol 1990, 32:432-441.
8. Enato E., Moretti M., Koren G. The fetal safety of benzodiazepines: an updated meta analysis. J Obstet Gynaecol Can 2011, 33(1):46-48.
9. Bellantuono C., Tofani S., Di Sciascio G., Santone G. Benzodiazepine exposure in pregnancy and risk of major malformations: a critical overview. Gen Hosp Psychiatry 2013, 35(1):3-8.
10. Iqbal M.M., Sobhan T., Ryals T. Effects of commonly used benzodiazepines on the fetus, the neonate and the nursing infant. Psychiatr Serv 2002, 53(1):39-49.
11. Yonkers K.A., Kando J.C., Cole J.O., Blumenthal S. Gender differences in pharmacokinetics and pharmacodynamics of psychotropic medication. Am J Psychiatry 1992, 149:587-595.
12. Allen M. Detoxification considerations in the medical management of substance abuse in pregnancy. Bull N Y Acad Med 1991, 67(3):270-276.
13. Rayburn W.F., Bogenschutz M. Pharmacotherapy for pregnant women with addictions. Am J Obstet Gynecol 2004, 191:1885-1897.
14. Smith E.J., Lui S., Terplan M. Pharmacologic interventions for pregnant women enrolled in alcohol treatment. Cochrane Database Syst Rev 2009, 3:1-15.